retatrutide gip glp-1 glucagon receptor agonist PDB-101: Molecule of the Month: Agonists Glucagon-like peptide-1 receptor: mechanisms and

New evidence from the FDA has recently shown that taking Ozempic can significantly increase the risk of gastroparesis, a very serious gastrointestinal condition

For those of us who can struggle with emotional or stress eating tendencies, we have to recognize that we have created a habit of seeking emotional relief through snacking, and this habit and the quick dopamine spikes that we get as a result will not stop without conscious effort

These medications mimic the effects of the bodys natural GLP-1 hormone, helping regulate blood sugar, curb appetite, and slow digestion a combination that supports both metabolic health and fat loss

December 13, 2024

Prescription: If eligible, your provider will write a prescription and guide you on a proper dose-escalation schedule